Enhanced Recovery After Surgery for Total Knee Arthroplasty, Left Colectomy and Hysterectomy

NCT ID: NCT03552913

Last Updated: 2018-06-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1710 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-07-06

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the study is to assess retrospectively the effect of an awareness-raising phase in favour of Enhanced Recovery After Surgery across the Assistance Publique-Hopitaux Paris institution and to explore the determinants of compliance with modalities of Enhanced Recovery After Surgery. This multicenter study is performed for three types of surgery: total knee arthroplasty, left colectomy and hysterectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary goal of the study is to quantify the effect of an awareness-raising phase in favour of Enhanced Recovery After Surgery which was organized in 2016 within the public hospitals in Paris (Assistance Publique - Hôpitaux de Paris).

The study aims to document and compare the compliance with fast track modalities and its impact for the year before (2015) and the year following (2017) the awareness-raising phase. Durations of hospital stay, compliance with recommendations, benefits on lowering complication rates and cost reductions will be studied for three types of interventions: total knee arthroplasty, left colectomy and hysterectomy.

Preoperative information provided to patients, counselling and physical optimisation will be evaluated through a survey among physicians whereas compliance with pre-, intra- and postoperative patient management guidelines will be retrospectively retrieved from the medical records of randomly selected patients. Survival and hospital trajectories will be obtained through the centralised national medical data system.

Three groups of patients having underwent total hip prosthesis, ovariectomy or gastrectomy in the same years (2015 and 2017) will serve as control groups, as for these surgeries no specific program has been implemented toward any practice change.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery Total Knee Arthroplasty Colectomy Hysterectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2015 Total knee arthroplasty, hysterectomy or left colectomy

Group of patients having a total knee arthroplasty, hysterectomy or left colectomy in 2015

One year before awareness-raising phase in favour of Enhanced Recovery After Surgery

Intervention Type PROCEDURE

One year before awareness-raising phase in favour of Enhanced Recovery After Surgery

2017 Total knee arthroplasty, hysterectomy or left colectomy

Group of patients having a total knee arthroplasty, hysterectomy or left colectomy in 2017

One year after awareness-raising phase in favour of Enhanced Recovery After Surgery

Intervention Type PROCEDURE

One year after awareness-raising phase in favour of Enhanced Recovery After Surgery

2015 Total hip prosthesis, ovariectomy or gastrectomy

Group of patients having total hip prosthesis, ovariectomy or gastrectomy in 2015

No specific program toward improving practices

Intervention Type PROCEDURE

No specific program toward improving practices

2017 Total hip prosthesis, ovariectomy or gastrectomy

Group of patients having total hip prosthesis, ovariectomy or gastrectomy in 2017

No specific program toward improving practices

Intervention Type PROCEDURE

No specific program toward improving practices

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

One year before awareness-raising phase in favour of Enhanced Recovery After Surgery

One year before awareness-raising phase in favour of Enhanced Recovery After Surgery

Intervention Type PROCEDURE

One year after awareness-raising phase in favour of Enhanced Recovery After Surgery

One year after awareness-raising phase in favour of Enhanced Recovery After Surgery

Intervention Type PROCEDURE

No specific program toward improving practices

No specific program toward improving practices

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged \> 18 years;
* Resident in France;
* Patient who underwent surgery in 2015 or 2017

Exclusion Criteria

* Patient operated in emergency.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dominique Fletcher, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Service d'anesthésie-réanimation chirurgicale, Hôpital Ambroise Paré

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service d'anesthésie-réanimation chirurgicale, Hopital Ambroise Paré

Boulogne-Billancourt, Hauts-de-seine, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dominique Fletcher, MD, PhD

Role: CONTACT

+33 1 49 09 54 23

Anissa Belbachir, MD

Role: CONTACT

+33 1 58 41 15 17

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dominique Fletcher, MD

Role: primary

+33 1 49 09 54 23

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CRCCH16001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.